Austin, Texas, United States, September 8th, 2026, NewsDirect
- SS Innovations is scaling its SSi Mantra surgical robotic system from an established Indian base into international markets.
- Second-quarter revenue rose 39.4% year over year to $13.9 million, while 30 SSi Mantra systems were installed during the quarter.
- The company entered the second half of 2026 with 224 systems installed across 12 countries and more than 12,000 cumulative procedures.
- Potential regulatory clearance in the United States and CE marking in Europe could materially enlarge SSII’s addressable market.
- The investment case is seen as attractive because SSII is still early in its commercialization curve, although investors must weigh cash consumption, regulatory risk, and potential dilution against its growth prospects.
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, presents an attractive proposition for investors in the medical-technology sector. The company’s SSi Mantra system is being deployed at an increasing number of hospitals, surgeons are performing thousands of procedures with the platform, and SSII is beginning to establish an installed base outside its home market.
The latest quarterly figures show a company rapidly expanding from a relatively small original base. SSII reported second-quarter revenue of $13.9 million, an increase of 39.4% from the same period a year earlier. It installed 30 SSi Mantra systems during the…
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.IBN.ai
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.ai/Disclaimer
The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII
Corporate Communications
IBN
Austin, Texas
www.IBN.ai
512.354.7000 Office
[email protected]
Contact
IBN
www.InvestorBrandNetwork.com
[email protected]